메뉴 건너뛰기




Volumn 69, Issue 4, 2010, Pages 372-385

Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant

Author keywords

Cytotoxicity; Experimental autoimmune encephalomyelitis; Innate immunity; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Nodlike receptor; Pattern recognition receptor; TH17; Toll like receptor

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 17; MYELIN OLIGODENDROCYTE GLYCOPROTEIN 34-56; MYELIN OLIGODENDROCYTE GLYCOPROTEIN 74-96; PEPTIDE DERIVATIVE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

EID: 77950792006     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181d5d053     Document Type: Article
Times cited : (73)

References (37)
  • 1
    • 54149084585 scopus 로고    scopus 로고
    • Multiple sclerosis
    • Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17
    • (2008) Lancet , vol.372 , pp. 1502-1517
    • Compston, A.1    Coles, A.2
  • 2
    • 55349135951 scopus 로고    scopus 로고
    • Novel therapeutic strategies for multiple sclerosisVa multifaceted adversary
    • Lopez-Diego RS, Weiner HL. Novel therapeutic strategies for multiple sclerosisVa multifaceted adversary. Nat Rev Drug Discov 2008;7: 909-25
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 909-925
    • Lopez-Diego, R.S.1    Weiner, H.L.2
  • 3
    • 0038119771 scopus 로고    scopus 로고
    • The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system
    • 't Hart BA, Amor S. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system. Curr Opin Neurol 2003;16:375-83
    • (2003) Curr Opin Neurol , vol.16 , pp. 375-383
    • 'T Hart, B.A.1    Amor, S.2
  • 4
    • 2942585381 scopus 로고    scopus 로고
    • Evaluating the validity of animal models for research into therapies for immune-based disorders
    • 't Hart B, Amor S, Jonker M. Evaluating the validity of animal models for research into therapies for immune-based disorders. Drug Discov Today 2004;9:517-24
    • (2004) Drug Discov Today , vol.9 , pp. 517-524
    • 'T Hart, B.1    Amor, S.2    Jonker, M.3
  • 5
    • 0042532322 scopus 로고    scopus 로고
    • Heterologous immunity provides a potent barrier to transplantation tolerance
    • Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111:1887-95
    • (2003) J Clin Invest , vol.111 , pp. 1887-1895
    • Adams, A.B.1    Williams, M.A.2    Jones, T.R.3
  • 6
    • 35948988938 scopus 로고    scopus 로고
    • Cytomegalovirus infection: A driving force in human T cell immunosenescence
    • Koch S, Larbi A, Ozcelik D, et al. Cytomegalovirus infection: A driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007; 1114:23-35
    • (2007) Ann N y Acad Sci , vol.1114 , pp. 23-35
    • Koch, S.1    Larbi, A.2    Ozcelik, D.3
  • 7
    • 0031858641 scopus 로고    scopus 로고
    • Histopathological characterization of magnetic resonance imaging y detectable brain white matter lesions in a primate model of multiple sclerosis: A correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus)
    • 't Hart BA, Bauer J, Muller HJ, et al. Histopathological characterization of magnetic resonance imagingYdetectable brain white matter lesions in a primate model of multiple sclerosis: A correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am J Pathol 1998;153:649-63
    • (1998) Am J Pathol , vol.153 , pp. 649-663
    • 'T Hart, B.A.1    Bauer, J.2    Muller, H.J.3
  • 8
    • 4544287704 scopus 로고    scopus 로고
    • Modelling of multiple sclerosis: Lessons learned in a non-human primate
    • 't Hart BA, Laman JD, Bauer J, et al. Modelling of multiple sclerosis: Lessons learned in a non-human primate. Lancet Neurol 2004;3:589-97
    • (2004) Lancet Neurol , vol.3 , pp. 589-597
    • 'T Hart, B.A.1    Laman, J.D.2    Bauer, J.3
  • 9
    • 20444489218 scopus 로고    scopus 로고
    • Design of effective immunotherapy for human autoimmunity
    • Feldmann M, Steinman L. Design of effective immunotherapy for human autoimmunity. Nature 2005;435:612-19
    • (2005) Nature , vol.435 , pp. 612-619
    • Feldmann, M.1    Steinman, L.2
  • 10
    • 20244369427 scopus 로고    scopus 로고
    • Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice
    • Smith PA, Heijmans N, Ouwerling B, et al. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. Eur J Immunol 2005;35: 1311-19
    • (2005) Eur J Immunol , vol.35 , pp. 1311-1319
    • Smith, P.A.1    Heijmans, N.2    Ouwerling, B.3
  • 11
    • 41949097581 scopus 로고    scopus 로고
    • Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets
    • Jagessar SA, Smith PA, Blezer E, et al. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. J Neuropathol Exp Neurol 2008;67:326-40
    • (2008) J Neuropathol Exp Neurol , vol.67 , pp. 326-340
    • Jagessar, S.A.1    Smith, P.A.2    Blezer, E.3
  • 12
    • 40749120878 scopus 로고    scopus 로고
    • Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)Yinduced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells
    • Kap YS, Smith P, Jagessar SA, et al. Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)Yinduced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells. J Immunol 2008;180:1326-37
    • (2008) J Immunol , vol.180 , pp. 1326-1337
    • Kap, Y.S.1    Smith, P.2    Jagessar, S.A.3
  • 13
    • 0034661721 scopus 로고    scopus 로고
    • Myelin/oligodendrocyte glycoproteinYinduced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule
    • Brok HP, Uccelli A, Kerlero De Rosbo N, et al. Myelin/oligodendrocyte glycoproteinYinduced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule. J Immunol 2000;165: 1093-101
    • (2000) J Immunol , vol.165 , pp. 1093-1101
    • Brok, H.P.1    Uccelli, A.2    Kerlero De Rosbo, N.3
  • 14
    • 0030697438 scopus 로고    scopus 로고
    • Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
    • Kerlero de Rosbo N, Hoffman M, Mendel I, et al. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 1997;27: 3059-69
    • (1997) Eur J Immunol , vol.27 , pp. 3059-3069
    • Kerlero De Rosbo, N.1    Hoffman, M.2    Mendel, I.3
  • 15
    • 33947522227 scopus 로고    scopus 로고
    • Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis
    • Blezer EL, Bauer J, Brok HP, et al. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed 2007;20:90-103
    • (2007) NMR Biomed , vol.20 , pp. 90-103
    • Blezer, E.L.1    Bauer, J.2    Brok, H.P.3
  • 16
    • 0032578397 scopus 로고    scopus 로고
    • The common marmoset: A new world primate species with limited MHC class II variability
    • Antunes SG, de Groot NG, Brok H, et al. The common marmoset: A new world primate species with limited MHC class II variability. Proc Natl Acad Sci U S A 1998;95:11745-50
    • (1998) Proc Natl Acad Sci U S A , vol.95 , pp. 11745-11750
    • Antunes, S.G.1    De Groot, N.G.2    Brok, H.3
  • 17
    • 0035576147 scopus 로고    scopus 로고
    • An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin
    • Brok HP, Hornby RJ, Griffiths GD, et al. An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. Cytometry 2001;45:294-303
    • (2001) Cytometry , vol.45 , pp. 294-303
    • Brok, H.P.1    Hornby, R.J.2    Griffiths, G.D.3
  • 18
    • 0035451355 scopus 로고    scopus 로고
    • Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses
    • Boon L, Brok HP, Bauer J, et al. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J Immunol 2001;167: 2942-49
    • (2001) J Immunol , vol.167 , pp. 2942-2949
    • Boon, L.1    Brok, H.P.2    Bauer, J.3
  • 19
    • 2942737198 scopus 로고    scopus 로고
    • The third signal in T cellmediated autoimmune disease?
    • Darabi K, Karulin AY, Boehm BO, et al. The third signal in T cellmediated autoimmune disease? J Immunol 2004;173:92-99
    • (2004) J Immunol , vol.173 , pp. 92-99
    • Darabi, K.1    Karulin, A.Y.2    Boehm, B.O.3
  • 20
    • 19944427519 scopus 로고    scopus 로고
    • Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease
    • Visser L, Jan de Heer H, Boven LA, et al. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol 2005;174:808-16
    • (2005) J Immunol , vol.174 , pp. 808-816
    • Visser, L.1    Jan De Heer, H.2    Boven, L.A.3
  • 21
    • 0037111199 scopus 로고    scopus 로고
    • Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs
    • de Vos AF, van Meurs M, Brok HP, et al. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol 2002;169:5415-23
    • (2002) J Immunol , vol.169 , pp. 5415-5423
    • De Vos, A.F.1    Van Meurs, M.2    Brok, H.P.3
  • 22
    • 0037376324 scopus 로고    scopus 로고
    • Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls
    • Van der Aa A, Hellings N, Bernard CC, et al. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. J Neuroimmunol 2003;137:164-76
    • (2003) J Neuroimmunol , vol.137 , pp. 164-176
    • Van Der Aa, A.1    Hellings, N.2    Bernard, C.C.3
  • 23
    • 0030005837 scopus 로고    scopus 로고
    • Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity
    • Kataoka T, Shinohara N, Takayama H, et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996; 156:3678-86
    • (1996) J Immunol , vol.156 , pp. 3678-3686
    • Kataoka, T.1    Shinohara, N.2    Takayama, H.3
  • 24
    • 0036199624 scopus 로고    scopus 로고
    • Marmoset fine B cell and T cell epitope specificities mapped onto a homology model of the extracellular domain of human myelin oligodendrocyte glycoprotein
    • Mesleh MF, Belmar N, Lu CW, et al. Marmoset fine B cell and T cell epitope specificities mapped onto a homology model of the extracellular domain of human myelin oligodendrocyte glycoprotein. Neurobiol Dis 2002;9:160-72
    • (2002) Neurobiol Dis , vol.9 , pp. 160-172
    • Mesleh, M.F.1    Belmar, N.2    Lu, C.W.3
  • 25
    • 0035217962 scopus 로고    scopus 로고
    • Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
    • Billiau A, Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 2001;70: 849-60
    • (2001) J Leukoc Biol , vol.70 , pp. 849-860
    • Billiau, A.1    Matthys, P.2
  • 26
    • 14844323664 scopus 로고    scopus 로고
    • Severe T-cell depletion from the PALS leads to altered spleen composition in common marmosets with experimental autoimmune encephalomyelitis (EAE)
    • De Vos AF, van Riel DA, van Meurs M, et al. Severe T-cell depletion from the PALS leads to altered spleen composition in common marmosets with experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol 2005;161:29-39
    • (2005) J Neuroimmunol , vol.161 , pp. 29-39
    • De Vos, A.F.1    Van Riel, D.A.2    Van Meurs, M.3
  • 27
    • 65249175159 scopus 로고    scopus 로고
    • C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
    • Reboldi A, Coisne C, Baumjohann D, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009;10:514-23
    • (2009) Nat Immunol , vol.10 , pp. 514-523
    • Reboldi, A.1    Coisne, C.2    Baumjohann, D.3
  • 28
    • 4444297090 scopus 로고    scopus 로고
    • Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination
    • von Büdingen HC, Hauser SL, Ouallet JC, et al. Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur J Immunol 2004;34:2072-83
    • (2004) Eur J Immunol , vol.34 , pp. 2072-2083
    • Von Büdingen, H.C.1    Hauser, S.L.2    Ouallet, J.C.3
  • 29
    • 0035031517 scopus 로고    scopus 로고
    • Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination
    • von Büdingen HC, Tanuma N, Villoslada P, et al. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol 2001;21:155-70
    • (2001) J Clin Immunol , vol.21 , pp. 155-170
    • Von Büdingen, H.C.1    Tanuma, N.2    Villoslada, P.3
  • 30
    • 0030002224 scopus 로고    scopus 로고
    • A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule
    • Vergelli M, Le H, van Noort JM, et al. A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule. J Immunol 1996;157:679-88
    • (1996) J Immunol , vol.157 , pp. 679-688
    • Vergelli, M.1    Le, H.2    Van Noort, J.M.3
  • 31
    • 0032519963 scopus 로고    scopus 로고
    • Non-MHC-restricted cellmediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression
    • Antel JP, McCrea E, Ladiwala U, et al. Non-MHC-restricted cellmediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression. J Immunol 1998;160:1606-11
    • (1998) J Immunol , vol.160 , pp. 1606-1611
    • Antel, J.P.1    McCrea, E.2    Ladiwala, U.3
  • 32
    • 33846829507 scopus 로고    scopus 로고
    • NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis
    • Saikali P, Antel JP, Newcombe J, et al. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J Neurosci 2007;27:1220-28
    • (2007) J Neurosci , vol.27 , pp. 1220-1228
    • Saikali, P.1    Antel, J.P.2    Newcombe, J.3
  • 33
    • 1042299971 scopus 로고    scopus 로고
    • Expression of major histocompatibility complex class i molecules on the different cell types in multiple sclerosis lesions
    • Hoftberger R, Aboul-Enein F, Brück W, et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol 2004;14:43-50
    • (2004) Brain Pathol , vol.14 , pp. 43-50
    • Hoftberger, R.1    Aboul-Enein, F.2    Brück, W.3
  • 34
    • 33947587491 scopus 로고    scopus 로고
    • Preclinical safety testing of monoclonal antibodies: The significance of species relevance
    • Chapman K, Pullen N, Graham M, et al. Preclinical safety testing of monoclonal antibodies: The significance of species relevance. Nat Rev Drug Discov 2007;6:120-26
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 120-126
    • Chapman, K.1    Pullen, N.2    Graham, M.3
  • 35
    • 48849087125 scopus 로고    scopus 로고
    • Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: A phase II, doubleblind, placebo-controlled, randomised, dose-ranging study
    • Segal BM, Constantinescu CS, Raychaudhuri A, et al. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: A phase II, doubleblind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008;7:796-804
    • (2008) Lancet Neurol , vol.7 , pp. 796-804
    • Segal, B.M.1    Constantinescu, C.S.2    Raychaudhuri, A.3
  • 36
    • 0036884860 scopus 로고    scopus 로고
    • Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti- IL-12p40 monoclonal antibody
    • Brok HP, Van Meurs M, Blezer E, et al. Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti- IL-12p40 monoclonal antibody. J Immunol 2002;169:6554-63
    • (2002) J Immunol , vol.169 , pp. 6554-6563
    • Brok, H.P.1    Van Meurs, M.2    Blezer, E.3
  • 37
    • 25444476685 scopus 로고    scopus 로고
    • Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody
    • 't Hart BA, Brok HP, Remarque E, et al. Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody. J Immunol 2005;175: 4761-68
    • (2005) J Immunol , vol.175 , pp. 4761-4768
    • 'T Hart, B.A.1    Brok, H.P.2    Remarque, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.